Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
LMT Surgical recalls its PyroTitan should joint resurfacing implant after finding a 3% failure rate, most of which occurred within 1 year of implantation. In consultation with Australian health authorities, LMT Surgical issued a warning to all surgeons who implanted the company's PyroTitan shoulder implant, advising of a reported 3% failure rate in the devices.
Help employers find you! Check out all the jobs and post your resume.
LMT Surgical recalls its PyroTitan should joint resurfacing implant after finding a 3% failure rate, most of which occurred within 1 year of implantation. In consultation with Australian health authorities, LMT Surgical issued a warning to all surgeons who implanted the company's PyroTitan shoulder implant, advising of a reported 3% failure rate in the devices.
Help employers find you! Check out all the jobs and post your resume.
